ArticleBioresources and bioprocessing2026
Multi-AOP: a lightweight multi-view deep learning framework for antioxidant peptide discovery.
Article in Bioresources and bioprocessing, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Proteome-Scale Discovery and Multilevel Validation of Antioxidant Short Peptides fromAntioxidants (Basel, Switzerland) · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
Abstract
Antioxidant peptides (AOPs), with their strong free radical scavenging ability and health benefits, have emerged as promising candidates for disease prevention and food preservation. However, traditional experimental approaches to AOP discovery remain hindered by inefficiencies and substantial resource demands. Here, we present Multi-AOP, a parameter lightweight multi-view deep learning framework (0.75 million parameters) that enhances AOP discovery through integrated sequence and graph learning. We employ Extended Long Short-Term Memory (xLSTM) to generate sequence embeddings. Concurrently, we transform peptide sequences into SMILES representations and extract molecular graph features using a Message Passing Neural Network (MPNN), capturing intrinsic physicochemical properties. By leveraging both sequence patterns and structural information through hierarchical fusion, Multi-AOP achieves accuracies of 0.8043, 0.9684, and 0.9043 on the AnOxPePred, AnOxPP, and AOPP benchmark datasets, respectively, consistently outperforming conventional machine learning algorithms and state-of-the-art deep learning approaches. Furthermore, we constructed a unified AOP dataset by integrating these benchmark datasets, facilitating the future development of generalizable AOP models. All datasets and the optimized predictive model are publicly accessible at https://github.com/CaiJianxiu/Multi-AOP .
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.